Hollis-Eden Pharmaceuticals Inc. ¡æ Harbor BioSciences Inc.
|
|
|
|
|
Apoptone (HE3235)- in the cohort expansion portion of a Phase I/IIa trial of patients with late-stage prostate cancer and Triolex¢ç- in a Phase IIa trial in obese type 2 diabetes mellitus patients | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|